Boston Scientific Corp.

Organisation

300 Boston Scientific Way, Marlborough, MA, United States, 01752-1234

Headquarters

59000

Employees

Health Technology

Industry

Michael Mahoney

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Price

Target

Boston Scientific Corp. (BSX) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Boston Scientific Corp. (BSX) share price will touch around $102 in next 12-months.

Currently 37 wall-street analysts regularly analyze the financials of Boston Scientific Corp. on a frequent basis to provide recommendations along with target share price. 37 analysts offering 12-month price forecasts for Boston Scientific Corp. (BSX) have a share price target of $102. This median of share price forecast represents a 47.44% upside from the latest price of $69.18 as on 29.03.26.

Boston Scientific Corp. (BSX) Share Price Forecast

Home

US Stocks

Boston Scientific Corp. (BSX)

Boston Scientific Corp. Stock Forecast

Boston Scientific Corp. Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Boston Scientific Corp. (BSX): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Boston Scientific Corp.'s share price and its median forecast price. As on 29.03.26, the difference is -19.74%

Boston Scientific Corp. Forecast and Target Price

Boston Scientific Corp. (BSX) Share Price Forecast

Boston Scientific Corp. (BSX) Price vs Consensus Price Target

Boston Scientific Corp. (BSX) Share Price Forecast v/s Share Price Today

Boston Scientific Corp. (BSX): Difference between Current Price & Median Forecasted Price

Boston Scientific Corp. (BSX) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price